Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DAPTOMYCIN Cause Dermatitis exfoliative? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Dermatitis exfoliative have been filed in association with DAPTOMYCIN (daptomycin). This represents 0.1% of all adverse event reports for DAPTOMYCIN.

7
Reports of Dermatitis exfoliative with DAPTOMYCIN
0.1%
of all DAPTOMYCIN reports
0
Deaths
4
Hospitalizations

How Dangerous Is Dermatitis exfoliative From DAPTOMYCIN?

Of the 7 reports, 4 (57.1%) required hospitalization, and 1 (14.3%) were considered life-threatening.

Is Dermatitis exfoliative Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DAPTOMYCIN. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does DAPTOMYCIN Cause?

Off label use (791) Drug ineffective (658) Product use in unapproved indication (654) Eosinophilic pneumonia (575) Acute kidney injury (501) Blood creatine phosphokinase increased (461) Pyrexia (447) Eosinophilia (405) Rhabdomyolysis (383) Drug reaction with eosinophilia and systemic symptoms (307)

What Other Drugs Cause Dermatitis exfoliative?

CIPROFLOXACIN (91) ALLOPURINOL (86) SULFAMETHOXAZOLE\TRIMETHOPRIM (75) CLOPIDOGREL BISULFATE (73) FUROSEMIDE (73) ATORVASTATIN (71) AMLODIPINE (70) ACETAMINOPHEN (66) VANCOMYCIN (66) SIMVASTATIN (64)

Which DAPTOMYCIN Alternatives Have Lower Dermatitis exfoliative Risk?

DAPTOMYCIN vs DARATUMUMAB DAPTOMYCIN vs DARATUMUMAB\HYALURONIDASE-FIHJ DAPTOMYCIN vs DARBEPOETIN ALFA DAPTOMYCIN vs DARIDOREXANT DAPTOMYCIN vs DARIFENACIN HYDROBROMIDE

Related Pages

DAPTOMYCIN Full Profile All Dermatitis exfoliative Reports All Drugs Causing Dermatitis exfoliative DAPTOMYCIN Demographics